Crissy Buchanan Carlisle - Jul 1, 2022 Form 4/A - Amendment Insider Report for Enhabit, Inc. (EHAB)

Role
Chief Financial Officer
Signature
/s/ Sarah Braley, Attorney in Fact
Stock symbol
EHAB
Transactions as of
Jul 1, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
5/1/2023, 04:01 PM
Date Of Original Report
Jul 6, 2022
Previous filing
Jun 17, 2022
Next filing
May 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EHAB Common Stock Other $0 +8.93K $0.00 8.93K Jul 1, 2022 Direct F1
transaction EHAB Common Stock Other $0 +17.4K +194.67% $0.00 26.3K Jul 1, 2022 Direct F2
transaction EHAB Common Stock Other $0 +9.76K +37.07% $0.00 36.1K Jul 1, 2022 Direct F3
transaction EHAB Common Stock Award $0 +22K +60.96% $0.00 58.1K Jul 1, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the spin-off of Enhabit, Inc. ("Enhabit") by Encompass Health Corporation ("Encompass") on July 1, 2022, Encompass distributed all of the issued and outstanding shares of Enhabit common stock to Encompass stockholders (the "Distribution"). Encompass stockholders received one share of Enhabit common stock for every two shares of Encompass common stock held as of the close of business on June 24, 2022. The number of shares of Enhabit common stock reported reflects the number of shares of Enhabit common stock received pursuant to the Distribution.
F2 Performance share units originally granted by Encompass were converted to Enhabit restricted stock units on the date of the Distribution. The restricted stock units have vesting dates consistent with the original awards from Encompass.
F3 Restricted stock awards originally granted by Encompass were converted to Enhabit restricted stock awards on the date of the Distribution. The restricted stock awards have vesting dates consistent with the original awards from Encompass.